Cleavage-resistant RIPK1-induced autoinflammatory syndrome-A report of three generations with periodic fever and clinical response to colchicine

Int J Rheum Dis. 2024 Jan;27(1):e14837. doi: 10.1111/1756-185X.14837. Epub 2023 Jul 15.

Abstract

The clinical syndrome caused by cleavage-resistant RIPK1 is known as CRIA (Cleavage-resistant RIPK1-induced autoinflammatory) syndrome. We present a family with three generations affected by CRIA syndrome. Our index patient (P1), a boy born of a non-consanguineous marriage, developed recurrent episodes of fever after 5 months of age, with variable periodicity. His father (P2) and paternal grandmother also had periodic fever. At 23 months of age, P1 was diagnosed with renal biopsy-proven steroid-responsive nephrotic syndrome. His first visit to our center was at 2 years of age. At presentation, he had failure to thrive, microcytic hypochromic anemia, and elevated inflammatory markers and interleukin-6 levels. Amyloid A protein was elevated, serum creatinine was normal, and proteinuria resolved after addition of steroids. Next-generation sequencing showed heterozygous mutation (c.970G>A, p.Asp324His) in RIPK1. This mutation has been reported to cause CRIA syndrome. P2 and P1's asymptomatic younger brother had the same mutation. All the affected members showed variability with respect to frequency and duration of periodic fever as well as the age of onset. Both P1 and P2 had elevated amyloid A, with no evidence of renal dysfunction. P1 and P2 showed improvement in the intensity of fever spikes with colchicine treatment; however, both continue to have periodic fever.

Keywords: CRIA syndrome; RIPK1; autoinflammatory disease; periodic fever.

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis* / diagnosis
  • Colchicine / therapeutic use
  • Familial Mediterranean Fever* / diagnosis
  • Fever / diagnosis
  • Fever / drug therapy
  • Fever / genetics
  • Humans
  • Male
  • Mutation
  • Receptor-Interacting Protein Serine-Threonine Kinases / genetics
  • Receptor-Interacting Protein Serine-Threonine Kinases / therapeutic use

Substances

  • Colchicine
  • RIPK1 protein, human
  • Receptor-Interacting Protein Serine-Threonine Kinases